Nike shares dropped 3.2% on August 17, 2026, to their lowest level since December 2016, pushing total market capitalization below $60 billion. The decline extends a prolonged slide for the athletic apparel maker as it navigates a turnaround with soft sales and competitive pressure.
Nike shares dropped 3.2% on August 17, 2026, to their lowest level since December 2016, pushing total market capitalization below $60 billion. The decline extends a prolonged slide for the athletic apparel maker as it navigates a turnaround with soft sales and competitive pressure.
Nike shares fell 3.2% on August 17, 2026, to their lowest level since December 2016, pushing total market capitalization below $60 billion.
JPMorgan downgraded Nike to Underweight, warning that the company's "Win Now" plan may be a long game with financial impact expected in fiscal 2027-2028, according to analyst coverage published in August.
The stock traded at $40.73 on August 16 with a $60.42 billion market cap and a 52-week range of $40.00 to $80.17, according to MarketBeat data. The most recent quarter, reported June 30, showed revenue of $10.97 billion, down 1.1% year over year, while EPS of $0.20 beat the $0.11 consensus. Analysts maintain a consensus Hold rating with an average price target of $53.53, implying roughly 31% upside from current levels.
The decline reflects persistent weakness in consumer demand and competitive pressure in the athletic apparel market, with the stock down 35.2% from prior reference levels. Nike's next earnings report is scheduled for October 1, 2026, when investors will assess whether the turnaround is gaining traction.
The latest decline follows a string of earnings beats that have failed to lift the stock. Nike delivered EPS of $0.72 in Q4 FY26 against a consensus estimate of $0.13, a positive surprise of 466%, driven largely by gross margin improvements supported by tariff recoveries and turnaround efforts. Revenue in that quarter came in at $10.97 billion with net earnings of $1.07 billion. Earlier quarters showed smaller positive gaps, including Q1 FY26 with EPS of $0.49 versus an estimate of $0.27 and Q2 FY26 with EPS of $0.53 versus $0.37.
Sales growth has been volatile, with year-over-year readings of -2.90%, -4.21%, and -1.57% across recent quarters before a positive 3.98% reading appeared in the sequence. The company has prioritized margin resilience and product mix optimization while investing selectively in growth initiatives.
Forward estimates show fiscal 2027 EPS of $1.72 and fiscal 2028 EPS of $2.23, implying year-over-year growth of 8.44% and 34.05%, respectively. Zacks noted those estimates moved lower in the past 30 days, pointing to a market that still wants proof that logistics, inventory discipline, and product mix can translate into cleaner growth.
The analyst breakdown shows 39 analysts in coverage, with 18 Hold ratings, 13 Buy ratings, five Sell ratings, and one Strong Buy, according to MarketBeat. Price targets range from a low of $23 to a high of $94, with Barclays at $52 and Evercore at $46.
The legal overhang has eased somewhat. Reuters reported on August 13 that the U.S. Equal Employment Opportunity Commission dropped a subpoena lawsuit after Nike complied, though the underlying investigation remains open.
Nike's product portfolio spans running, basketball, soccer, training, apparel, and footwear sold through wholesale, stores, and direct-to-consumer channels. The company's Air Force and Air Max franchises remain key platforms, and premium launches like the Nike Mind 001 AMP at $150 support the product cycle. Competitors including Deckers Outdoor, On Holding, and Birkenstock continue to pressure Nike's market share in the athletic footwear space.
The decline puts Nike at its lowest valuation since 2016, testing whether the turnaround narrative can hold. Investors will watch the October 1 earnings report for signs that revenue growth is stabilizing and margin gains are durable.
This article is for informational purposes only and does not constitute investment advice.
